Nuwellis Inc vs Roundhill NVDA WeeklyPay ETF — how do they compare? Nuwellis Inc trades at $0.68 (market cap $2.20M), while Roundhill NVDA WeeklyPay ETF trades at $37.17 (market cap $119.10M). The key difference: Roundhill NVDA WeeklyPay ETF is far larger — about 54.1× Nuwellis Inc's market cap, and Roundhill NVDA WeeklyPay ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Roundhill NVDA WeeklyPay ETF for 50 Days on average.
| NUWE | NVDW | |
|---|---|---|
Market Cap | $2.20M | $119.10M |
Volume | 121,544 | 44,838 |
Sector | Health | Income / Options Overlay |
52-Week High | $146.65 | $52.33 |
52-Week Low | $0.68 | $31.88 |
Typical Hold Time | 26 Days | 50 Days |
Enterprise Value | -$1.52M | — |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →NVDW is an actively managed ETF that seeks to provide weekly distributions and returns equal to 1.2 times (120%) the calendar week performance of Nvidia (NVDA) common shares. It combines modest leverage with a high-frequency payout schedule, designed for investors who want amplified exposure to Nvidia alongside a consistent weekly income stream.
Read more on NVDW →